Tech Company Financing Transactions

Mariana Oncology Funding Round

Deep Track Capital, Forbion Ventures Fund VI and Access Biotechnology participated in a $175 million Series B capital raise for Mariana Oncology. The financing round was announced on 9/7/2023.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

100 Forge 6th Floor
Watertown, MA 02472
USA

Phone

Undisclosed

Website

www.marianaoncology.com

Email Address

Undisclosed

Overview

Mariana Oncology creates medicines to treat cancer's toughest tumors by harnessing the power of precisely-delivered radiation. We are preserving lives through a better standard of care and envision a world where cancer care is transformed by precision radiopharmaceuticals and a future in which these drugs are incorporated into mainstream treatment. We are a fully integrated next-generation radiopharmaceutical company powered by experts in ligand discovery, radiochemistry, radiobiology, and oncology translational and clinical research, building a pipeline across a range of solid tumor types.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Simon Read

        

Chief Operating Officer

Linda Bain

        

Chief Scientific Officer

Alonso Ricardo

        

Chief Technical Officer

Bernard Lambert

        

Browse more venture capital transactions:

Prev: 9/7/2023: Mission Control venture capital transaction
Next: 9/7/2023: Skyqraft venture capital transaction

Share this article

Where The Data Comes From

We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary